| PERIOD ENDING | 31-Dec-08 | | Total Revenue |
-
| | Cost of Revenue |
-
| | | Gross Profit |
-
| | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 3,832 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | (3,832) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12 | | Earnings Before Interest And Taxes | (3,821) | | Interest Expense | 0 | | Income Before Tax | (3,821) | | Income Tax Expense |
-
| | Minority Interest |
-
| | | | Net Income From Continuing Ops | (3,821) | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (3,821) | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | ($3,821) |
|
0.14% Nasdaq 
Income Statement
